Personalized Anesthesia: The Role of the Locus Coeruleus in Individual Anesthetic Responses
个性化麻醉:蓝斑在个体麻醉反应中的作用
基本信息
- 批准号:10799159
- 负责人:
- 金额:$ 13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdrenergic AgentsAffectAnesthesia proceduresAnestheticsAnxiety DisordersArousalBehavioralBrainCaringCognitionCognitiveComputing MethodologiesConsciousDoseElectroencephalographyGeneral AnesthesiaGeneticGoalsIndividualIndividual DifferencesInvestigationLifeMeasuresMethodsMonitorMusNeural PathwaysNeuronsNeurotransmittersOperative Surgical ProceduresPathway interactionsPatientsPerioperativePharmaceutical PreparationsPharmacologyPharmacology StudyPost-Traumatic Stress DisordersResistanceRoleSystemTimeUnconscious Stateawakecognitive functioncostdensitydrug sensitivityexperiencegenetic approachindividual patientindividual responselocus ceruleus structureneurophysiologypharmacologicpopulation basedpostoperative deliriumresponse
项目摘要
PROJECT SUMMARY/ABSTRACT
Millions of patients are placed into a reversible state of unconsciousness by anesthesiologists for life saving
surgeries every year. The basic goals of anesthetic care are to reliably extinguish consciousness for the
duration of surgery and afterwards swiftly return the patient to their baseline cognitive state. Neither one of
these goals can be reliably achieved today, however. Some patients regain consciousness during surgery.
Episodes of consciousness are not reliably detected by current intraoperative EEG-based monitoring and can
result in post-traumatic stress and anxiety disorders. In contrast, other patients take a long time to resume
normal cognition. This can manifest as postoperative delirium and cognitive derangements. Postoperative
delirium affects millions of patients, costs 34 billion dollars annually, and can itself be a harbinger of cognitive
dcline after surgery. Such persistent decrements in cognitive function can last for many months. It is presently
unclear why some patients experience peri-anesthetic complications while other patients that receive
seemingly identical anesthetics have an uneventful perioperative course. To address this, we propose to
study individual-based anesthetic pharmacology rather than previously used population-based measures.
We have recently developed experimental and computational methods to quantify individual-based
measures of anesthetic responses in mice. The use of these methods revealed that conventional
population-based pharmacological concepts such as drug potency are not sufficient to describe individual
responses. We identified two independent measures that do capture the range of individual responses:
sensitivity and resistance to state transitions (Rst). Sensitivity describes how often an individual is awake or
anesthetized at an anesthetic dose, while Rst describes how frequently transitions happen between those two
states. We demonstrated that sensitivity and Rst can be differentially pharmacologically modulated. We also
demonstrated that chemogenetic activation of an arousal pathway – locus coeruleus – decreases Rst without a
change in drug sensitivity. Because Rst is completely obscured in population-based pharmacological studies,
we hypothesize that Rst is the “hidden variable” that may help explain why some patients experience
peri-anesthetic complications while others do not.
We propose to investigate the mechanisms through which the locus coeruleus decreases Rst. Using
pharmacologic and genetic approaches, we will identify the neurotransmitter systems used by the locus
coeruleus to modulate Rst. Separately, we will identify the effects of the locus coeruleus on neurophysiologic
state change, including correlates of behavioral Rst, using a high-density EEG system developed by our lab.
Finally, we will turn towards identifying the neuronal pathways through which locus coeruleus acts to modulate
Rst. The proposed lines of investigation will clarify how activity of the locus coeruleus influences individualized
anesthetic responses, and will be an important step towards delivering personalized anesthesia.
项目摘要/摘要
麻醉师为挽救生命而将数百万患者置于可逆的无意识状态
每年的手术。麻醉护理的基本目标是可靠地消除意识
手术持续时间,然后迅速将患者归还其基线认知状态。两个都不是
但是,今天可以可靠地实现这些目标。一些患者在手术期间继续意识。
当前基于脑电图的监测目前无法检测到意识发作,无法可靠,并且可以
导致创伤后压力和焦虑症。相反,其他患者需要很长时间才能恢复
正常认知。这可以表现为术后del妄和认知演变。术后
ir妄影响数百万患者,每年成本为340亿美元,并且本身可以成为认知的预兆
手术后的DCLINE。这种认知功能的持续减少可以持续数月。现在是
尚不清楚某些患者为什么会经历麻醉周期并发症,而其他接受的患者
看似相同的麻醉剂具有平稳的周期性课程。为了解决这个问题,我们建议
研究基于个体的麻醉药理学,而不是以前使用的基于人群的措施。
我们最近开发了实验和计算方法来量化基于个体的基于个体的方法
小鼠麻醉反应的度量。这些方法的使用表明传统
基于人群的药物概念(例如药物效力)不足以描述个体
回答。我们确定了确实捕获个体响应范围的两种独立措施:
敏感性和对状态过渡(RST)的抵抗力。敏感性描述了一个人醒的频率或
在麻醉剂量上进行麻醉,而RST描述了这两个之间发生过渡的频率
国家。我们证明了敏感性和RST可以差异化。我们也是
证明唤醒途径的化学发生激活 - 层基因座 - 在没有a的情况下下降
药物敏感性的变化。由于RST在基于人群的药物研究中完全掩盖了
我们假设RST是“隐藏变量”,它可能有助于解释某些患者体验的原因
骨检查并发症而其他并没有。
我们建议研究核基因座降低的机制。使用
药理学和遗传方法,我们将确定该基因座使用的神经递质系统
凝结以调节rst。另外,我们将确定层层基因座对神经生理学的影响
使用我们实验室开发的高密度EEG系统,包括行为rST的相关性,包括行为rst的相关性。
最后,我们将转向识别神经元途径,该途径通过该途径进行调节
第拟议的投资线将阐明基因座的活动如何影响个性化
麻醉反应,将是提供个性化麻醉的重要一步。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
One node among many: sevoflurane-induced hypnosis and the challenge of an integrative network-level view of anaesthetic action.
许多节点中的一个:七氟烷诱导的催眠和麻醉作用的综合网络级视图的挑战。
- DOI:10.1016/j.bja.2023.11.002
- 发表时间:2024
- 期刊:
- 影响因子:9.8
- 作者:McKinstry-Wu,AndrewR;Kelz,MaxB
- 通讯作者:Kelz,MaxB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Rich McKinstry-Wu其他文献
Andrew Rich McKinstry-Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Rich McKinstry-Wu', 18)}}的其他基金
Personalized Anesthesia: The Role of the Locus Coeruleus in Individual Anesthetic Responses
个性化麻醉:蓝斑在个体麻醉反应中的作用
- 批准号:
10274962 - 财政年份:2021
- 资助金额:
$ 13万 - 项目类别:
Personalized Anesthesia: The Role of the Locus Coeruleus in Individual Anesthetic Responses
个性化麻醉:蓝斑在个体麻醉反应中的作用
- 批准号:
10665091 - 财政年份:2021
- 资助金额:
$ 13万 - 项目类别:
Intersections of Sleep and Coma: Neural Pathways of Alpha-2 Adrenergic Hypnosis
睡眠与昏迷的交叉点:Alpha-2 肾上腺素催眠的神经通路
- 批准号:
9906236 - 财政年份:2017
- 资助金额:
$ 13万 - 项目类别:
Intersections of Sleep and Coma: Neural Pathways of Alpha-2 Adrenergic Hypnosis
睡眠与昏迷的交叉点:Alpha-2 肾上腺素催眠的神经通路
- 批准号:
9293823 - 财政年份:2017
- 资助金额:
$ 13万 - 项目类别:
Intersections of Sleep and Coma: Neural Pathways of Alpha-2 Adrenergic Hypnosis
睡眠与昏迷的交叉点:Alpha-2 肾上腺素催眠的神经通路
- 批准号:
10361385 - 财政年份:2017
- 资助金额:
$ 13万 - 项目类别:
相似国自然基金
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
β2肾上腺素能受体基因多态性Arg16Gly影响慢性心衰预后及 β受体阻滞剂疗效的机制研究
- 批准号:81800356
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
β-受体拮抗剂对曲妥珠单抗的增效作用及其机制研究
- 批准号:81773258
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
β2肾上腺素能受体激动剂通过cAMP/PKA通路调控MSCs旁分泌在急性肺损伤修复中的作用和机制
- 批准号:81500058
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
选择性β1肾上腺素能受体阻断剂抗骨质疏松的作用及机理研究
- 批准号:81300710
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 13万 - 项目类别:
The role of S-glutathione in regulating cardiac myosin binding protein-C function
S-谷胱甘肽在调节心肌肌球蛋白结合蛋白-C功能中的作用
- 批准号:
10749281 - 财政年份:2023
- 资助金额:
$ 13万 - 项目类别:
Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
- 批准号:
10718104 - 财政年份:2023
- 资助金额:
$ 13万 - 项目类别:
Ryanodine receptor structure and function in heart failure
Ryanodine 受体结构和心力衰竭中的功能
- 批准号:
10628917 - 财政年份:2023
- 资助金额:
$ 13万 - 项目类别:
Locus coeruleus-norepinephrine regulation of stress-induced anxiety and opioid reinstatement
蓝斑-去甲肾上腺素对应激性焦虑和阿片类药物恢复的调节
- 批准号:
10677132 - 财政年份:2023
- 资助金额:
$ 13万 - 项目类别: